B Lymphoblastic Lymphoma: Clinical Trials

2 trials for B Lymphoblastic Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Active not recruiting 1, Recruiting 1

Follow B Lymphoblastic Lymphoma: new trials by email Literature Review of B Lymphoblastic Lymphoma trials Research Report on B Lymphoblastic Lymphoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3RecruitingChildren's Oncology Group59512019-10-312026-08-25
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
Asparaginase Erwinia chrysanthemi, Blinatumomab, Cyclophosphamide - B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3Active not recruitingNational Cancer Institute (NCI)67202019-07-032026-10-01

Narrower conditions

Burkitt Lymphoma (2)  ·  Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Down Syndrome (1)  ·  Leukemia, Biphenotypic, Acute (1)

Broader conditions

DNA Virus Infections (2)  ·  Epstein-Barr Virus Infections (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Herpesviridae Infections (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Infections (2)  ·  Leukemia (2)  ·  Leukemia, Lymphoid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoma (2)  ·  Lymphoma, B-Cell (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Lymphoproliferative Disorders (2)

Interventions

Asparaginase (2)  ·  Calcium Dobesilate (2)  ·  Cyclophosphamide (2)  ·  Cytarabine (2)  ·  Dexamethasone (2)  ·  Doxorubicin (2)  ·  Leucovorin (2)  ·  Mercaptopurine (2)  ·  Methotrexate (2)  ·  Methylprednisolone (2)  ·  N,N-dicyclohexyl-isoborneol-10-sulfonamide (2)  ·  Prednisolone (2)  ·  Prednisone (2)  ·  Radiation (2)  ·  Radiotherapy (2)

Sponsors

Children's Oncology Group (1)  ·  National Cancer Institute (NCI) (1)

Countries

Australia (2)  ·  Canada (2)  ·  New Zealand (2)  ·  Puerto Rico (2)  ·  United States (2)

Top investigators

Jennifer L McNeer (1)  ·  Sumit Gupta (1)

Results publications

PMID 33844429, PMID 39651791, PMID 41671463

NIH funding

U10CA180886 (2)